Abbott India outperformed the Indian pharmaceutical market (IPM) with a year-on-year (YoY) growth of 23 per cent in February. Photograph: Shailesh Andrade/Reuters The domestic market grew at a......
The US drug regulator raised the issue of significant deviations from the current good manufacturing practice (cGMP) in three of DRRD's plants in a letter issued in November 2015 Investors......
India's pharmaceutical industry is expected to see sales and profit growth accelerate in the second half of the year, thanks to a pickup in the pace of US. approvals for new drugs, offsetting any......
Indian drugmakers expect a slowdown in new generic drug approvals by the US Food and Drug Administration (FDA) to weigh on sales in their largest market for at least two more quarters, due to an......
Employees at global pharma giant Pfizer allege it is cutting its work force in India by insisting they take a voluntary retirement scheme (VRS). The said scheme appears to cover its field force, as......